Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -29.36x as of the fiscal period ended Tuesday, December 31, 2019.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-29.36x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.24x
median of 359 covered companies
CURRENT VS SECTOR MEDIAN
-592.56%
vs the sector median at left
Immunovant, Inc.
Market Cap
$6.75B
Interest Coverage Ratio
-29.36x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$6.68B
Interest Coverage Ratio
193.28x
TTM Avg
199.58x
3Y Avg
145.92x
5Y Avg
155.47x
Market Cap
$6.55B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.04B
Interest Coverage Ratio
20.69x
TTM Avg
19.66x
3Y Avg
19.10x
5Y Avg
16.50x
Market Cap
$6.53B
Interest Coverage Ratio
15.74x
TTM Avg
19.48x
3Y Avg
15.56x
5Y Avg
15.56x
Market Cap
$6.52B
Interest Coverage Ratio
1.75x
TTM Avg
1.35x
3Y Avg
1.23x
5Y Avg
1.08x
Market Cap
$7.25B
Interest Coverage Ratio
-4.22x
TTM Avg
7.50x
3Y Avg
4.09x
5Y Avg
4.09x
Market Cap
$6.00B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | $6.75B | -29.36x | N/A | N/A | N/A |
| GRAIL Inc. (GRAL)vs › | $6.74B | N/A | N/A | N/A | N/A |
| Chemed Corporation (CHE)vs › | $6.68B | 193.28x | 199.58x | 145.92x | 155.47x |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.55B | N/A | N/A | N/A | N/A |
| Alkermes plc (ALKS)vs › | $7.04B | 20.69x | 19.66x | 19.10x | 16.50x |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.53B | 15.74x | 19.48x | 15.56x | 15.56x |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.52B | 1.75x | 1.35x | 1.23x | 1.08x |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.25B | -4.22x | 7.50x | 4.09x | 4.09x |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $6.00B | N/A | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $6.12B | 10.01x | 10.01x | 9.97x | 7.31x |
Interest Coverage
-29.4x
Debt/Equity
0.00
Current Ratio
7.27
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2019-12-31 | -29.36x |
